VG Life Sciences, Inc. Reports On Clinical Outcomes In Phase 1 Cancer Study

Published: Mar 14, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SANTA BARBARA, Calif., March 14, 2014 (GLOBE NEWSWIRE) -- VG Life Sciences, (OTC Pink:VGLS) a biotechnology company, announces today an update to its Physician-IND Phase I Study to test tolerability and toxicity of its patented technology in patients with advanced stage solid tumors.

Help employers find you! Check out all the jobs and post your resume.

Back to news